GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonistprotocol: a randomized, controlled double blind study | Zendy

Barış Ata | Zendy; Kayhan Yakın | Zendy; Başak Balaban | Zendy; Bülent Urman | Zendy

Open Access

GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonistprotocol: a randomized, controlled double blind study

Author(s) -

Barış Ata,

Kayhan Yakın,

Başak Balaban,

Bülent Urman

Publication year - 2008

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dem421

Subject(s) - triptorelin , medicine , agonist , pregnancy rate , luteal phase , randomization , pregnancy , placebo , intracytoplasmic sperm injection , embryo transfer , gynecology , randomized controlled trial , in vitro fertilisation , gonadotropin releasing hormone , hormone , biology , luteinizing hormone , receptor , genetics , alternative medicine , pathology

GnRH agonist administration in the luteal phase was reported to beneficially affect the clinical outcome of intracytoplasmic sperm injection (ICSI) and embryo transfer (ET) cycles. This double blind, randomized, placebo controlled trial evaluates whether a single dose GnRH agonist administered 6 days after ICSI increases ongoing pregnancy rates following ET in cycles stimulated with the long GnRH agonist protocol.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research